KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276,388 | -31.3% | 19,884 | +13.7% | 0.00% | – |
| Q2 2023 | $402,187 | -46.1% | 17,494 | -30.6% | 0.00% | – |
| Q1 2023 | $746,705 | +42.6% | 25,201 | +20.1% | 0.00% | – |
| Q4 2022 | $523,686 | +50.5% | 20,981 | +31.3% | 0.00% | – |
| Q3 2022 | $348,000 | -12.3% | 15,976 | -20.8% | 0.00% | – |
| Q2 2022 | $397,000 | -71.9% | 20,176 | -39.5% | 0.00% | -100.0% |
| Q1 2022 | $1,412,000 | -37.3% | 33,366 | -5.9% | 0.00% | 0.0% |
| Q4 2021 | $2,251,000 | +7.6% | 35,450 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $2,092,000 | +125.9% | 35,619 | +86.5% | 0.00% | – |
| Q2 2021 | $926,000 | +250.8% | 19,100 | +181.0% | 0.00% | – |
| Q1 2021 | $264,000 | -42.6% | 6,798 | -8.3% | 0.00% | – |
| Q4 2020 | $460,000 | – | 7,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |